Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Authors:
- Volker DiehlVDVolker Diehl
- Michael FuchsMFMichael Fuchs
- 31 August 2007
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 37 (1) , 37-41
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano LinfomiJournal of Clinical Oncology, 2005
- Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).Blood, 2004
- Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 2003
- 14-Day Variant of the Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Regimen in Advanced-Stage Hodgkin’s Lymphoma: Results of a Pilot Study of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup TrialJournal of Clinical Oncology, 2003
- Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical TrialJournal of Clinical Oncology, 2002
- MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.Journal of Clinical Oncology, 1998
- Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's diseaseAnnals of Oncology, 1996
- Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group studyCancer, 1983
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975